Drug Markets/Interferon Beta-1b

Interferon Beta-1b

1 NDC across 1 manufacturer|0 Generic,1 Brand

Interferon Beta-1b is used to treat brain neoplasms, hepatocellular carcinoma, renal cell carcinoma, colorectal neoplasms, cryoglobulinemia and hemangioma, per the National Library of Medicine's MED-RT classification.

▸ More about this market

In 2024, Medicare Part D spent $93 million on Interferon Beta-1b across 9,209 claims for 1,073 beneficiaries.

Interferon Beta-1b is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $725.97 to $725.97 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$725.97 – $725.97

per EA

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing INTERFERON BETA-1B

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
BETASERON 0.3 MG KIT
$725.9747
per EA
—

Frequently Asked Questions

What is Interferon Beta-1b used to treat?

Interferon Beta-1b is used to treat brain neoplasms, hepatocellular carcinoma, renal cell carcinoma, colorectal neoplasms, cryoglobulinemia and hemangioma, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Interferon Beta-1b?

In 2024, Medicare Part D spent $93 million on Interferon Beta-1b across 9,209 claims for 1,073 beneficiaries.

How many Interferon Beta-1b products are on the market?

The Interferon Beta-1b drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Interferon Beta-1b?

NADAC reference prices for Interferon Beta-1b range from $725.9747 to $725.9747 per EA.

Which manufacturers make Interferon Beta-1b?

1 manufacturer lists Interferon Beta-1b in NADAC. Ranked by number of NDCs, the largest are Bayer HealthCare Pharmaceuticals Inc. (1).